Skip to content
Yog Pharma

Metformin Hydrochloride is a biguanide indicated for type 2 diabetes mellitus. We supply it to US manufacturers of tablets, extended-release tablets, oral solution and fixed-dose combinations.

CAS1115-70-4165.6 g/molC4H12ClN5
2D structure of Metformin Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 14219) and FDA’s substance registry

CAS number

1115-70-4

Molecular formula

C4H12ClN5

Molecular weight

165.6g/mol

FDA UNII

IUPAC name

3-(diaminomethylidene)-1,1-dimethylguanidine;hydrochloride

InChIKey

OETHQSJEHLVLGH-UHFFFAOYSA-N

Appearance
White to off-white crystalline compound.
Solubility
Freely soluble in water, slightly soluble in alcohol, and practically insoluble in acetone and methylene chloride.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

A high-volume API where bulk density and particle size decide how it runs on your line. Since the 2020 recalls of extended-release tablets, NDMA data on the API is a standard request.

On the US market

Reference product
GlucophageNDA 020357
Approved ANDAs
57 with a marketed product
Approved forms and strengths
  • Extended-release tablet 500 mg, 750 mg, 1 g
  • Tablet 500 mg, 625 mg, 750 mg, 850 mg, 1 g
  • Oral solution 500 mg/5 mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com